# AMG0103 in Subjects With Chronic Discogenic Lumbar Back Pain

> **NCT03263611** · PHASE1 · COMPLETED · sponsor: **AnGes, Inc.** · enrollment: 25 (actual)

## Conditions studied

- Degenerative Disc Disease

## Interventions

- **DRUG:** Placebo
- **DRUG:** AMG0103

## Key facts

- **NCT ID:** NCT03263611
- **Lead sponsor:** AnGes, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-26
- **Primary completion:** 2021-02-15
- **Final completion:** 2021-02-15
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2021-10-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03263611

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03263611, "AMG0103 in Subjects With Chronic Discogenic Lumbar Back Pain". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03263611. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*